Pune: Serum Institute of India (SII) has sought approval from Drugs Controller General of India (DCGI) for Covishield to be administered in the form of booster dose.
In an application to drugs regulator DCGI, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute, has cited adequate vaccine stock in India and a necessity for a booster shot especially after the emergence of new coronavirus variants, PTI reported quoting sources.
SII further mentioned that UK’s Medicines and Healthcare products Regulatory Agency has already approved booster dose of Oxford-AstraZeneca’s ChAdOx1 nCoV-19 vaccine. Since Serum Institute is manufacturing the same vaccine in a different brand name (Covishield), it’s only logical that India should embrace it.
Also Read: Omicron-Specific Booster Shot Possible, Says Adar Poonawala
Unlike countries like the US, UK, Germany, India has not decided on introducing a booster shot for its citizens. But a decision on the matter may be announced soon.
Also Read: COVID Vaccine: Policy On Booster & Additional Dose To Be Made Public In 2 Weeks
Bhubaneswar: A 20-year-old married woman, allegedly kidnapped from Odisha's Nabarangpur and then raped, and held…
New York: Slamming the prolonged delays in some parts of United States, Elon Musk on…
Cuttack: Madhupatana Police recently rescued a 17-year-old Bangladeshi girl, a suspected victim of trafficking and…
Mumbai: With the Bharatiya Janata Party (BJP), Shiv Sena and the NCP alliance emerging victorious in…
Balasore: The driver of a container truck was charred to death after the vehicle caught…
Nuapada: At least 80 people were arrested during a massive crackdown on illegal gambling activities…
Bhubaneswar: The Odisha government has transferred Special Secretary, Planning and Convergence, Chitra Arumugam and posted…
Sambhal: A violent clash erupted in Uttar Pradesh’s Sambhal on Sunday after a group opposed…